Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients

Between May 1990 and March 1995, 5 of 29 young patients (ages 4.2-25 years; median 14.1 years) undergoing RF ablation for atrioventricular node reentrant tachycardia (AVNRT) presented with spontaneous accelerated junctional rhythm (AJR) (CL = 500-750 ms), compared to 0 of 58 age matched controls undergoing RF ablation for a concealed AV accessory pathway (P = 0.004). In 3 of the 5 patients with AVNRT and AJR, junctional beats served as a trigger for reentry. During attempted slow pathway modification in the five patients with AVNRT and AJR, AVNRT continued to be inducible until the AJR was entirely eliminated or dramatically slowed. These 5 patients are tachycardia-free in followup (median 15 months; range 6-31 months) with only 1 of the 5 patients continuing to experience episodic AJR at rates slower than observed preablation. Episodic spontaneous AJR is statistically associated with AVNRT in young patients and can serve as a trigger for reentry. Successful modification of slow pathway conduction may be predicted by the elimination of AJR or its modulation to slower rates, suggesting that the rhythm is secondary to enhanced automaticity arising near or within the slow pathway.

Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature

Transient interruption of accessory pathway (AP) conduction is often encountered during creation of RF lesions, with return of conduction after seconds to weeks. Maximum catheter tip temperature (Tmax) has not been shown to be a good predictor of successful RF ablation. However, other indices related to catheter tip temperature (T) may predict permanent AP interruption. Ninety-one successful RF applications in 58 patients (mean age 11.9 +/- 5.5 years, 38 WPW syndrome, 18 concealed AP, 2 both) were reviewed retrospectively. Forty-two RF applications were transiently successful, with a median time of AP conduction recurrence of 120 seconds (sec; range, 1 sec to > 1 day). This group was compared with 49 permanently successful RF applications. T was measured and controlled using the Medtronic Atakr system (San Jose, CA, USA). RF lesion duration, power output, Tmax and time to Tmax (tmax) were not significantly different between the two groups. By univariate analysis, each of the following indices was able to discriminate between the transient and permanent lesions, and highly correlated with one another, T at the moment of AP interruption (Tsucc; transient 55.0 +/- 7.9 degrees C vs permanent 49.8 +/- 7.7 degrees C, P = 0.0025), time to success (tsucc; transient 4.0 +/- 3.0 sec vs permanent 1.8 +/- 1.3 sec, P = 0.0001), ratio of Tsucc/Tmax (transient 0.76 +/- 0.23 vs permanent 0.57 +/- 0.27, P = 0.0007) and ratio of tsucc/tmax (transient 0.91 +/- 0.69 vs permanent 0.41 +/- 0.41, P = 0.0001). By logistic regression analysis, no single variable or combination of variables was superior to tsucc for prediction of outcome, with a breakpoint of 2.3 seconds having a sensitivity of 74% and a specificity of 65%. During temperature controlled RF application, indices of time and temperature were well-correlated with permanent elimination of AP conduction. Time to interruption of AP conduction < 2.3 seconds after the onset of RF application was predictive of the permanence of successful RF applications. Known relations between RF lesion volume and catheter tip temperature suggest that early conduction block may be an indicator of anatomical proximity of the catheter tip and the AP. These data suggest that, in conjunction with electrogram criteria, selection criteria for optimal sites for RF, application may continue to be refined after the onset of RF application, and support the practice of terminating RF application if AP conduction is not rapidly interrupted.

Anxiety, antisocial behavior, and heart rate regulation in adolescent males

We explored relationships between anxiety and antisocial behavior and autonomic heart rate regulation in a homogenous sample (N = 175) of 15-year-old males. Measures of anxiety and antisocial behavior were obtained at yearly intervals over a period of 4-6 years. Components of heart rate variability associated with postural (sympathetic) and respiratory (vagal) change and transfer of respiratory to heart rate variability were estimated at age 15 using spectral analytic techniques. Anxiety and antisocial behavior were predictably related to enhanced and diminished levels of mean heart rate, respectively. Anxiety was also predictably related to enhanced sympathetic mediation of phasic postural effects on heart rate. Antisocial behavior was unexpectedly related to disruption of vagally mediated, phasic respiratory effects on heart rate. Anxiety and antisocial behavior showed distinct relationships to heart rate, and to the autonomically mediated components of heart rate variability from postural and respiratory sources. Spectral analytic techniques helped elucidate these unique regulatory patterns, suggesting utility for future research in this area.

Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease

OBJECTIVES

This study sought to 1) develop an efficient treatment protocol for postoperative automatic junctional tachycardia (JT) using conventional drugs and techniques, and 2) identify clinical features associated with this disorder by analyzing a large study group.

BACKGROUND

Postoperative JT is a transient arrhythmia that may be fatal after operation for congenital cardiac defects. Its precise cause is unknown. A variety of palliative treatments have evolved, but because of a low incidence of JT, large studies of the most efficient therapeutic sequence are lacking.

METHODS

A protocol for rapid JT (>170 beats/min) was adopted in 1986, and was tested in 71 children between 1986 and 1994. Staged therapy involved 1) a reduction of catecholamines; 2) correction of fever; 3) atrial pacing to restore synchrony; 4) digoxin; 5) phenytoin or propranolol or verapamil; 6) procainamide or hypothermia; and 7) combined procainamide and hypothermia. Effective therapy was defined as a sustained reduction of JT rate <170 beats/min within 2 h. Clinical profiles of the study group were contrasted with all patients without JT from this same era to identify features associated with JT.

RESULTS

Of the multiple treatment stages, only correction of fever and combined procainamide and hypothermia appeared to be efficacious. By refining the protocol to eliminate nonproductive stages, the time to JT control was significantly shortened for the last 30 patients. Treatment was ultimately successful in 70 of 71 children. Postoperative JT was strongly associated with young age, transient atrioventricular block and operations involving ventricular septal defect closure.

CONCLUSIONS

A staged approach to therapy, with emphasis on combined hypothermia and procainamide in difficult cases, appears to be an effective management strategy for postoperative JT. These results may also serve as comparison data for evaluation of newer and promising JT options, such as intravenous amiodarone. Trauma to conduction tissue may play a central role in the etiology of this disorder.

Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping

INTRODUCTION

The anatomic substrate of intra-atrial reentrant tachycardia (IART) following congenital heart surgery is poorly understood, but is presumed to be different than common atrial flutter.

METHODS AND RESULTS

To study the mechanisms of IART, we used a new technique for high-density endocardial mapping using recordings from a multipolar basket recording catheter (25 bipolar pairs). For each recording, biplane fluorographic reference points were digitized to obtain the spatial locations of electrode pairs, and activation times were calculated using temporal reference points from the surface ECG. Using custom software, data were combined to create three-dimensional atrial activation sequence maps, which were displayed as animated sequences. Using this technique, recordings were made in induced and/or spontaneous IART in 8 patients following congenital heart surgery (5 Fontan, 2 tetralogy of Fallot repair, 1 ventricular septal defect repair), and in 3 patients with normal intracardiac anatomy (1 with type I atrial flutter). Ten discrete IART activation sequences were recorded; 2 patients had 2 sequences each. IART maps were constructed using a median of 108 electrode positions (range 27 to 197) from a median of 6 recordings/sequence (range 3 to 11). Sinus or paced atrial rhythms were also recorded, and maps were created in a similar fashion. Visual analysis of activation sequences of sinus and paced rhythm were anatomically concordant with known mechanisms of atrial activation. IART sequences revealed diverse mechanisms; only 1 IART circuit was similar to that associated with common atrial flutter. Activation wavefront emergence from presumed zones of slow conduction, lines of conduction block, and apparent bystander activation were observed.

CONCLUSIONS

High-density atrial activation sequence maps demonstrate that IART following congenital heart surgery utilizes diverse circuits and is distinct from common atrial flutter. The technique used to create these three-dimensional activation sequences may improve understanding of these complex atrial arrhythmias and assist in the development of ablative therapies.

A comparison of volume conductor effects on body surface Laplacian and potential ECGS: a model study

The objective of this investigation is to study, using a computer model, the torso volume conductor effects on body surface potential electrograms and body surface Laplacian electrograms. A spherical volume conductor model was used to approximate the torso and the heart. Myocardial electrical events were approximated by two distributed dipole-layers representing activation wavefronts propagating from the endocardium to the epicardium. The present computer simulation results indicate that the body surface Laplacian maps provide enhanced performance over the body surface potential maps in resolving the configurations of two activation wavefronts over the anterior wall of the heart.

Halothane and cardiac autonomic control in infants: assessment with quantitative respiratory sinus arrhythmia

In comparison to adults, infants undergoing halothane anesthesia have an increased incidence of clinically significant episodes of bradycardia, hypotension, and cardiac arrest. To examine potential cardiac autonomic regulatory mechanisms that may account for these observations, the relationship between respiratory activity and short-term variations of heart rate was quantified in 10 healthy term nonpremedicated infants (28.4 +/- 0.6 wk old) undergoing elective surgery with halothane and low caudal anesthesia. Quantitative respiratory activity, heart rate, and cuff blood pressure data were obtained during the preoperative awake period, and at three depths of halothane--1, 1.3, and 2.0 mean alveolar concentration (MAC). Time and frequency domain analyses were performed on two 2.2-min epochs of data from each condition to yield mean values, spectral measures of low (0.02-0.15 Hz) and high (0.15-0.80 Hz) frequency power (LF and HF), and the LF/HF ratio. The sympathetic (As) and parasympathetic (Ap) components of respiratory sinus arrhythmia were quantified using the transfer relations between respiration and heart rate to derive gain factors Ax and Ap, respectively. Mean heart rate, blood pressure, and respiratory activity all decreased with halothane exposure (p < 0.01), but did not differ by halothane dose. Similarly, LF, HF, LF/HF, and respiratory powers all decreased with halothane, but not between doses. When the effects of respiratory activity on heart rate were accounted for, As decreased at 1.3 and 2.0 MAC only, but Ap remained unchanged. Decreased LF and HF power suggests that halothane altered both sympathetic and parasympathetic heart rate control; however, when the ratio between LF and HF and the quantitative effects of respiration are accounted for, halothane appears to cause a reduction in respiratory related sympathetic heart rate control, without a significant change in parasympathetic control.

Recurrence of conduction following radiofrequency catheter ablation procedures: relationship to ablation target and electrode temperature. The Atakr Multicenter Investigators Group

INTRODUCTION

More than 1 in 10 patients may develop recurrence of conduction after undergoing a successful radiofrequency catheter ablation procedure. The physiologic basis for recurrence following successful ablation procedures remains uncertain. The purpose of this study was to evaluate the role of electrode temperature as a predictor of recurrence following radiofrequency catheter ablation procedures.

METHODS AND RESULTS

The subjects of this study were 538 patients who underwent a successful attempt at radiofrequency catheter ablation of AV nodal reentrant tachycardia, an accessory pathway, and/or the AV junction. Patients were followed for a mean of 215 +/- 138 days. Conduction recurred in 35 (6.5%) of the 538 patients. Recurrence of conduction occurred in 25 (9.3%) of 270 patients undergoing ablation of an accessory pathway, 7 (3.5%) of 201 patients undergoing ablation of AV nodal reentrant tachycardia, and in 3 (4.5%) of 67 patients undergoing ablation of the AV junction. The electrode temperature achieved at successful sites associated with recurrence was not different from the temperature achieved at successful sites without recurrence (61.1 +/- 8.9 vs 61.6 +/- 9.1; P = 0.8). The likelihood of developing a recurrence was higher following ablation of accessory pathways than following ablation of AV nodal reentrant tachycardia or the AV junction (P = 0.03). Patients experiencing a recurrence following ablation of an accessory pathway had longer procedure durations (P = 0.0001). Ablation of left free-wall pathways was associated with a lower incidence of recurrence as compared with all other locations (P = 0.008).

CONCLUSION

The results of this study suggest that electrode temperature at the successful ablation site cannot be used to identify patients at highest risk of recurrence.

Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage

BACKGROUND

Temperatures near 50 degrees C can cause reversible loss of excitability in myocardial cells.

METHODS AND RESULTS

Low-temperature, short-duration applications of radiofrequency energy were used to determine the adequacy of electrophysiological mapping of accessory pathway (AP) locations in 15 patients at 27 target sites using a closed-loop, temperature-controlled generator set to 50 degrees C. Energy was delivered until evidence of conduction block, or for a maximum of 10 seconds. If AP block occurred, a full 70 degrees C set point radiofrequency application was delivered to the same site. In the absence of AP block, tests with higher temperature settings (60 degrees C and 70 degrees C) were delivered to determine if inadequate temperature or catheter position led to failure of the initial 50 degrees C test. At 15 successful target sites where permanent AP block was achieved, the 50 degrees C test resulted in AP block in 14 (93%). Conduction returned in 13 of 14 APs after radiofrequency power was turned off. The time to block for the 70 degrees C applications was significantly shorter than for the 50 degrees C tests, and the peak temperature achieved was significantly higher. At unsuccessful sites where permanent AP block was not achieved, no block was induced with 11 of 12 tests at 50 degrees C, 6 of 6 tests at 60 degrees C, and 1 of 2 tests at 70 degrees C, suggesting that failure was due to incorrect catheter position. The sensitivity and positive predictive values of a 50 degrees C test identifying a successful site were > 90%.

CONCLUSIONS

Low-temperature radiofrequency applications that cause transient AP block predict permanent success when a higher-temperature application is delivered at the same site. The time to achieve conduction block is a function of the temperature set point, and low-temperature tests produce reversible conduction block, suggesting minimal permanent injury.

Baroreflex gain: characterization using autoregressive moving average analysis

To study heart rate baroreflex gain, autoregressive moving average (ARMA) analysis, a multivariate method that allows evaluation of the dynamic ("beat-to-beat") interactions between changes in biological signals, was used to evaluate the relationships between R-R interval and arterial blood pressure (BP) during random-interval breathing. Parameters obtained by ARMA analysis of spontaneous fluctuations in BP and R-R interval in 17 volunteers were used to model the response of R-R interval to a transient 1-mmHg increase in BP; the resulting impulse-response and step-response curves were compared with baroreflex gain measured using bolus injections of phenylephrine (PE) and sodium nitroprusside (SNP). Impulse-response curves for the systolic BP-R-R relationship showed an early (0-1 s) sharp maximum of 5.5 +/- 4.2 ms/mmHg, which was smaller in magnitude but linearly correlated with baroreflex gain derived from SNP (14.5 +/- 9.7 ms/mmHg; r = 0.80, P < 0.002) and PE (31.6 +/- 26.7 ms/mmHg; r = 0.53, P < 0.05) injections. A similar relationship was also found between the one-beat ARMA step response and SNP injection (r = 0.70, P = 0.01). The integrated step response of the BP-R-R relationship over 6 s was 6.4 +/- 4.1 ms/mmHg, with no correlation to baroreflex gain determined by SNP (r = 0.33, P = 0.20) or PE (r = -0.15, P = 0.57). In conclusion, quantification of baroreflex gain consistent with other techniques may be achieved by ARMA analysis without perturbing mean BP. Correlation of baroreflex gain obtained by bolus injection to early measures of baroreflex gain obtained from the ARMA maximum impulse and early step responses, but not the late step response, suggests that the ARMA method may provide additional information regarding the frequency dependent effects of BP on R-R-interval.

Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group

Both early and late thromboembolic events are known complications of radiofrequency catheter ablation. This review of 758 patients undergoing 830 radiofrequency ablation procedures finds that embolic complications after radiofrequency ablation in patients without other risk factors for thromboembolism are rare (<0.2%).

Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants

To assess the efficacy and safety of current pharmacologic therapy for supraventricular tachycardia (SVT) in infants, we reviewed 112 infants treated between July 1985 and March 1993. The SVT mechanism was determined by esophageal electrophysiologic study and involved an accessory pathway in 86, atrioventricular (AV) node reentry in 10, atrial muscle reentry in 11, and an ectopic atrial tachycardia in 5 patients. Of six infants not treated, none had clinical recurrences of SVT. Of the 106 patients treated, 70% remained free of tachycardia while receiving digoxin, propranolol, or both. Class I antiarrhythmic agents were necessary for 13 patients, and class III agents were required for another 13 infants. Verapamil was used in one infant with AV node reentry tachycardia. Nine infants with complex clinical presentations were believed to have failed medical management and underwent radiofrequency ablation. Five patients died, four of complications related to structural heart disease and one shortly after radiofrequency ablation was performed. No deaths appeared to be related to antiarrhythmic medications. No drug-related side effects requiring medication change occurred, and no proarrhythmia was observed. Thus medical therapy appears to be effective and safe in infants with SVT. Radiofrequency ablation should be reserved for rare infants who fail aggressive medical regimens or when the situation is complicated by ventricular dysfunction, severe symptoms, or complex congenital heart disease.

High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings

The use of radiofrequency ablation for treatment of complex arrhythmia substrates has prompted interest in transcatheter endocardial activation mapping. Technical constraints on catheter fabrication and the intention to use such maps to guide ablation both demand innovative approaches to mapping. A fluoroscopically based endocardial mapping technique is proposed to improve the ability of electrophysiologists to interpret large amounts of data acquired using multielectrode catheter arrays, improving their ability to visualize the data and act on its content. This technique addresses previous limitations imposed by the number of electrodes that can be deployed and by the difficulty in determining their relative spatial locations. It is based on the composition of multiple activation sequence mappings made in a single rhythm, with the spatial locations of recording electrode pairs determined in orthogonal fluoroscopic views referenced to stable intrathoracic markers. Rather than imposing a geometry determined primarily by the measurement apparatus, the spatial locations of only those electrodes in proximity to the endocardial surface, as determined by their ability to record bipolar electrograms, are measured. In this manner, the geometry of the endocardium may be approximated by measurements made of electrode position. Using this approach, the number of endocardial sites that can be sampled in a stable rhythm is theoretically unlimited, resulting in the realization of high-resolution activation maps. Spatiotemporal data may be used to create three-dimensional activation sequence maps, displayed as animated sequences. This technique was used in anatomically normal and diseased human right atria to create activation maps of sinus and paced rhythms, classic atrial flutter, and postoperative intraatrial reentrant tachycardia, using a median of 108 electrode positions (range, 27-197) in 25 maps. The activation sequences represented by these maps were diverse, but qualitatively concordant with known mechanisms of atrial activation. High-density catheter-based activation mapping of the right atrium is feasible and may improve understanding of complex arrhythmias and assist in the development of ablative techniques. Further research is needed on the spatial correlation between cardiac anatomy and fluorography, suppression of spatial artifact, and optimal mapping densities.

Myocardial mechanics before and after ablation of chronic tachycardia

Chronic tachycardia has been shown to cause a congestive cardiomyopathy; however, previous methods of evaluating ventricular function are highly dependent on cardiac loading conditions. Mean velocity of fiber shortening and its relation to end-systolic wall stress (ESS) is a preload independent index of contractility that incorporates afterload. We reviewed 33 patients (aged 5 months to 20 years; mean 9.7 years) with ectopic atrial tachycardia (EAT) (n = 19), permanent junctional reciprocating tachycardia (PJRT) (n = 12), or ventricular tachycardia (n = 2), who underwent nonpharmacological elimination of tachycardia ; 28 by radiofrequency ablation and 5 surgically. Ventricular function was evaluated by echocardiographic measurements of shortening fraction, mean velocity shortening corrected for heart rate (VcFc), and afterload as ESS. Contractility, expressed as the stress-velocity index, was determined by comparing the Ess/VcFc relation to the predicted normal VcFc for the measured ESS. Myocardial dysfunction was seen in 21 patients: 13 with EAT; 7 with PJRT; and 1 with ventricular tachycardia. In patients with EAT, the mean heart rate in tachycardia was significantly faster in those with dysfunction than in those without dysfunction (176.8 +/- 23.2 vs 136.7 +/- 28.2; P < 0.02). Of the 21 patients with dysfunction, full recovery was seen in 17 of 18 patients restudied after intervention (mean 17.5 +/- 17.6 weeks), and the remaining patient improved markedly, but did not normalize entirely. Dysfunction, seen in 64% of young patients with chronic tachycardia, was due to depressed myocardial contractility, and is generally reversible within 3 months of definitive therapy.

Mechanisms and therapy of complex arrhythmias in pediatric patients

In recent years, the distinction between the diagnostic and therapeutic techniques used in the assessment and management of pediatric and adult patients with arrhythmias has gradually blurred. Nonetheless, arrhythmias in the pediatric patient are still often different from the adult patient in one of two important ways. First, a variety of arrhythmia mechanisms remain relatively unique to the pediatric population, some because of developmental issues and others because of early presentation of an incessant tachycardia. Second, the presentation and management of certain arrhythmias is sometimes markedly affected by patient age or the presence of structural congenital heart disease. A sampling from each of the above categories is reviewed and discussed.

Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome

Sotalol is an antiarrhythmic medication that has properties of both a beta-blocker and a class III agent and has been used safely and effectively to treat arrhythmias of multiple mechanisms in pediatric patients. The purpose of this study was to review our institutional experience with sotalol in 45 patients with refractory arrhythmias and determine their long-term outcome. Patients responded to sotalol with 80% efficacy and a 22% incidence of adverse side effects. The mean sotalol dose was 116 mg/m2/day, and the average duration of therapy was 15.2 months. In spite of 80% efficacy, only 22% of patients remained on sotalol long-term. Sotalol was discontinued most commonly for either spontaneous resolution of disease or definitive cure by radiofrequency ablation. Other reasons for discontinuation of effective therapy included adverse side effects and arrhythmia control with either an antitachycardia pacemaker or another medication. One patient died while taking sotalol, but this case was considered a failure of treatment rather than an adverse side effect. Of the patients who still receive therapy, several have complex structural heart disease and require a combination of therapies, including sotalol, for adequate rhythm control.

Time and frequency domain methods for heart rate variability analysis: a methodological comparison

The purpose of this paper is to analytically evaluate and compare two of the most common methods for measuring respiration-related heart rate fluctuations: linear detrended heart rate power spectral analysis and the Porges technique of filtered variance. Low-frequency power was removed from instantaneous 4-Hz R-R interval signals using either a first-order linear (linear/spectral technique) or a third-order polynomial (MPF-var technique). The signals were band-pass filtered and analyzed in both the time and frequency domains. Although in most cases the two techniques yielded substantially similar results, the MPF-var technique resulted in signal amplification at a few specific frequencies. The frequency range and effect to amplification of the MPF-var technique were dependent upon the polynomial size, sampling frequency, and frequency content of the signal.

Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure

Atrial reentry tachycardia, often termed atrial flutter, is an arrhythmia that is uncommon in the general pediatric population but is seen frequently in patients with congenital heart disease. One goal in treating the arrhythmia is to terminate it, returning the atrium to its underlying rhythm. This report describes the use of transesophageal atrial pacing to attempt termination of atrial reentry in 102 pediatric patients (158 episodes). The patients ranged in age from 1 hour to 41.5 years. Conversion was successful for 112 (71%) of 158 episodes. Six of the 112 episodes required an infusion of procainamide after initial attempts at pacing led to atrial fibrillation. There were no significant differences between the ages of patients or the duration of the tachycardia in comparing successful versus unsuccessful conversions. In contrast, the atrial cycle lengths for the successfully converted tachycardias were significantly greater than for unsuccessful attempts. Transesophageal atrial pacing is a safe and effective means of terminating atrial flutter in the pediatric population. It is minimally invasive, it can often be performed in an outpatient setting, and the technique may occasionally be facilitated by infusion of intravenous procainamide.

Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation

Adenosine can cause conduction block in about 20% of nondecremental accessory pathways. Along with atrial activation mapping, adenosine may help differentiate retrograde AV node conduction versus residual accessory pathway conduction after radiofrequency catheter ablation; however, it is important to test the accessory pathway response to adenosine before ablation, particularly with a concealed accessory pathway.

Respiratory sinus arrhythmia: time domain characterization using autoregressive moving average analysis

Fourier-based techniques are mathematically noncausal and are therefore limited in their application to feedback-containing systems, such as the cardiovascular system. In this study, a mathematically causal time domain technique, autoregressive moving average (ARMA) analysis, was used to parameterize the relations of respiration and arterial blood pressure to heart rate in eight humans before and during total cardiac autonomic blockade. Impulse-response curves thus generated showed the relation of respiration to heart rate to be characterized by an immediate increase in heart rate of 9.1 +/- 1.8 beats.min-1.l-1, followed by a transient mild decrease in heart rate to -1.2 +/- 0.5 beats.min-1.l-1 below baseline. The relation of blood pressure to heart rate was characterized by a slower decrease in heart rate of -0.5 +/- 0.1 beats.min-1.mmHg-1, followed by a gradual return to baseline. Both of these relations nearly disappeared after autonomic blockade, indicating autonomic mediation. Maximum values obtained from the respiration to heart rate impulse responses were also well correlated with frequency domain measures of high-frequency "vagal" heart rate control (r = 0.88). ARMA analysis may be useful as a time domain representation of autonomic heart rate control for cardiovascular modeling.

Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal

Blood pressure variability includes rhythmic and nonrhythmic fluctuations that, with the use of spectral analysis, appear as clear peaks or broadband power, respectively. This review offers a concise and critical description of the spectral methods most commonly used (fast Fourier transform versus autoregressive modeling, time-varying versus broadband spectral analysis) and an evaluation of their advantages and disadvantages. It also provides insight into the problems that still affect the physiological and clinical interpretations of data provided by spectral analysis of blood pressure and heart rate variability. In particular, the assessment of blood pressure and heart rate spectra aimed at providing indexes of autonomic cardiovascular modulation is discussed. Evidence is given that multivariate models--which allow evaluation of the interactions between changes in blood pressure, heart rate, and other biological signals (such as respiratory activity) in the time or frequency domains--offer a more comprehensive approach to the assessment of cardiovascular regulation than that represented by the separate analysis of fluctuations in blood pressure or heart rate only.

Factors influencing impedance during radiofrequency ablation in humans

Impedance during radiofrequency (RF) catheter ablation procedures is dependent on a variety of parameters related to the catheter, cabling, reference patch, body size, and temperature. To examine the influence of body size, impedance was measured during clinical ablation procedures in 93 patients (Group I) with a wide range of body sizes. In 14 other patients (Group II), impedance was measured during variations in catheter tip size (5, 6 and 7 Fr), reference patch size (120 and 60 cm2), patch location (chest vs. thigh), and catheter tip tissue contact. The average impedance was also compared to average tip temperature in Group II patients. Impedance decreased with increasing catheter tip size, reference patch size and proximity of the patch to the heart. However, the effects of body geometry were complex. For example, using a chest patch, impedance increased with body surface area, but using a thigh patch it decreased, suggesting that lung volume may increase impedance, but body width may actually decrease it. An increase in tip tissue contact, relative to blood contact, increased the impedance, suggesting that impedance may be a useful measure of tip tissue contact. Finally impedance decreased with increasing tip temperature, suggesting that impedance may be useful as a real time measure of tissue and blood heating. The results are interpreted in terms of an electrical analog which suggests further that despite the lower total power when the same voltage is applied to a higher impedance, less voltage should be applied to achieve the same tissue effect when the measured impedance is higher.

Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease

Atrial reentry tachycardia is common after surgical repair of congenital heart disease. The arrhythmia is often difficult to treat and is occasionally life-threatening. This study reports experience with atrial antitachycardia (AAIT mode) pacing for the management of atrial reentry tachycardia, with emphasis on the risks and benefits of automatic pacing therapy. Eighteen patients (2-32 years of age) with a variety of congenital heart lesions underwent atrial antitachycardia pacemaker placement for recurrent atrial tachycardia that was amenable to pace termination prior to the implantation procedure. An appropriate antitachycardia program was determined by repeated induction and termination of atrial tachycardia using the noninvasive programmed stimulation mode of the pacemaker. Over 4-30 months of follow-up, 6 patients had 189 episodes of tachycardia successfully converted with AAI-T pacing, 4 patients had 8 episodes of tachycardia detected but not successfully converted, and 8 patients had no episodes of tachycardia with antibradycardia pacing alone. The number of patients receiving pharmacological therapy other than digoxin or beta blockade fell from 12 to 6. Two subjects died suddenly, 1 while wearing a Holter monitor. In both, tachycardia was detected and pace cardioversion attempted.

CONCLUSIONS

Atrial antitachycardia pacing is a useful tool in the management of patients with congenital heart disease and atrial arrhythmias; however, in selected cases, it may not prevent and may even exacerbate the lethal complications of the tachycardia. Antitachycardia function evaluation is recommended under varying levels of autonomic stress prior to institution of automatic therapy.